Proper place of intrauterine transfusions in management of fetuses with Rh hemolytic disease.
D000032:Abortion, Therapeutic; D000653:Amniotic Fluid; D001805:Blood Transfusion, Intrauterine / Q000009:adverse effects; D004487:Edema / Q000628:therapy; D004899:Erythroblastosis, Fetal / Q000628:therapy*; D005260:Female; D005313:Fetal Death; D005315:Fetal Diseases / Q000628:therapy; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000209:etiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy; D012204:Rh-Hr Blood-Group System
D012204:Rh-Hr Blood-Group System